GT Biopharma Inc
GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein immune cell engager technology platforms. It develops GTB-3650, which is in preclinical studies that target CD33 on the surfa… Read more
GT Biopharma Inc (GTBP) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -1.226x
Based on the latest financial reports, GT Biopharma Inc (GTBP) has a cash flow conversion efficiency ratio of -1.226x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.68 Million) by net assets ($3.00 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GT Biopharma Inc - Cash Flow Conversion Efficiency Trend (1985–2024)
This chart illustrates how GT Biopharma Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
GT Biopharma Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GT Biopharma Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Afarak Group Oyj
HE:AFAGR
|
0.001x |
|
Tincorp Metals Inc.
OTCQX:TINFF
|
-0.007x |
|
Prg Holdings Bhd
KLSE:7168
|
-0.006x |
|
Anew Medical, Inc.
NASDAQ:WENA
|
0.274x |
|
ZYTRONIC PLC LS-01
F:8HD
|
N/A |
|
Ecoslops SA
PA:ALESA
|
0.068x |
|
Bt Brands Inc
NASDAQ:BTBD
|
0.042x |
|
LNG Energy Group Corp.
OTCQB:LNGNF
|
N/A |
Annual Cash Flow Conversion Efficiency for GT Biopharma Inc (1985–2024)
The table below shows the annual cash flow conversion efficiency of GT Biopharma Inc from 1985 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-1.67 Million | $-12.90 Million | 7.727x | +752.58% |
| 2023-12-31 | $7.48 Million | $-8.85 Million | -1.184x | +8.70% |
| 2022-12-31 | $11.73 Million | $-15.22 Million | -1.297x | -82.07% |
| 2021-12-31 | $21.91 Million | $-15.61 Million | -0.712x | -388.69% |
| 2020-12-31 | $-29.43 Million | $-7.26 Million | 0.247x | +30.21% |
| 2019-12-31 | $-19.31 Million | $-3.66 Million | 0.189x | +120.18% |
| 2018-12-31 | $11.37 Million | $-10.68 Million | -0.939x | -4252.64% |
| 2017-12-31 | $251.69 Million | $-5.43 Million | -0.022x | -121.15% |
| 2016-12-31 | $-18.92 Million | $-1.93 Million | 0.102x | +10.74% |
| 2015-12-31 | $-50.57 Million | $-4.66 Million | 0.092x | +55.72% |
| 2014-12-31 | $-29.57 Million | $-1.75 Million | 0.059x | -15.25% |
| 2013-12-31 | $-6.33 Million | $-442.00K | 0.070x | -55.20% |
| 2012-12-31 | $-6.34 Million | $-987.00K | 0.156x | -17.49% |
| 2011-12-31 | $-5.10 Million | $-963.00K | 0.189x | -32.74% |
| 2010-12-31 | $-5.47 Million | $-1.53 Million | 0.281x | +71.46% |
| 2009-12-31 | $-5.72 Million | $-937.00K | 0.164x | +256.45% |
| 2008-12-31 | $-3.68 Million | $-169.00K | 0.046x | +127.71% |
| 2007-12-31 | $1.63 Million | $-270.00K | -0.166x | +95.18% |
| 2006-12-31 | $195.00K | $-671.00K | -3.441x | -481.67% |
| 2005-12-31 | $3.54 Million | $-2.09 Million | -0.592x | -229.06% |
| 2004-12-31 | $5.80 Million | $-1.04 Million | -0.180x | +31.70% |
| 2003-12-31 | $870.00K | $-229.00K | -0.263x | +68.19% |
| 2002-12-31 | $1.22 Million | $-1.01 Million | -0.828x | +69.05% |
| 2001-12-31 | $533.00K | $-1.43 Million | -2.674x | -180.15% |
| 2000-12-31 | $4.07 Million | $-3.89 Million | -0.954x | -3.60% |
| 1999-12-31 | $2.69 Million | $-2.48 Million | -0.921x | -27.55% |
| 1998-12-31 | $7.20 Million | $-5.20 Million | -0.722x | -2.31% |
| 1997-12-31 | $6.80 Million | $-4.80 Million | -0.706x | +26.13% |
| 1996-12-31 | $4.50 Million | $-4.30 Million | -0.956x | +22.47% |
| 1995-12-31 | $4.30 Million | $-5.30 Million | -1.233x | -2164.53% |
| 1994-12-31 | $6.70 Million | $400.00K | 0.060x | +110.45% |
| 1993-12-31 | $2.80 Million | $-1.60 Million | -0.571x | -391.43% |
| 1992-12-31 | $4.30 Million | $-500.00K | -0.116x | -167.44% |
| 1991-12-31 | $4.60 Million | $-200.00K | -0.043x | -123.19% |
| 1990-12-31 | $4.80 Million | $900.00K | 0.188x | +4.46% |
| 1989-12-31 | $3.90 Million | $700.00K | 0.179x | +474.36% |
| 1988-12-31 | $3.20 Million | $100.00K | 0.031x | +93.75% |
| 1987-12-31 | $3.10 Million | $50.00K | 0.016x | +111.29% |
| 1986-12-31 | $2.80 Million | $-400.00K | -0.143x | -47.62% |
| 1985-12-31 | $3.10 Million | $-300.00K | -0.097x | -- |